TuHURA Biosciences, Inc. HURA Payment Of Net Liabilities Assumed In Reverse Recapitalization
Payment Of Net Liabilities Assumed In Reverse Recapitalization at other companies
Other financials
Where this comes from
Reported directly by TuHURA Biosciences, Inc. in its filing.
Tagged under the XBRL concept hura:PaymentOfNetLiabilitiesAssumedInReverseRecapitalization.
The official record: TuHURA Biosciences, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about TuHURA Biosciences, Inc.'s payment of net liabilities assumed in reverse recapitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TuHURA Biosciences, Inc.'s payment of net liabilities assumed in reverse recapitalization?
- TuHURA Biosciences, Inc. (HURA) reported payment of net liabilities assumed in reverse recapitalization of $550K in Q1 2025.
- How has TuHURA Biosciences, Inc.'s payment of net liabilities assumed in reverse recapitalization changed year-over-year?
- TuHURA Biosciences, Inc.'s payment of net liabilities assumed in reverse recapitalization increased by 176.1% year-over-year, from $199.23K to $550K.
- What does payment of net liabilities assumed in reverse recapitalization mean?
- Represents cash outflows related to the settlement of liabilities acquired during a reverse recapitalization transaction. This metric tracks the actual cash impact of fulfilling obligations inherited from the private entity that merged into the public shell company.